The Penetration Question: How Colostrum's Growth Factors Actually Reach Your Skin

If you've researched growth factors in skincare, you've probably encountered the penetration objection. Growth factors are large proteins—typically 10,000 to 30,000 daltons in molecular weight. The stratum corneum, your skin's outermost barrier, generally doesn't allow molecules larger than 500 daltons to penetrate easily.

So how can topically applied colostrum, rich in these large growth factor proteins, possibly work?

This is a fair question that deserves an honest, scientifically-grounded answer.

The 500 Dalton Rule: What It Actually Means

The "500 dalton rule" comes from research by pharmacologist Bos and colleagues, who found that molecules smaller than 500 daltons can typically pass through intact stratum corneum. This rule of thumb has been useful for drug delivery research—and has caused legitimate skepticism about topical growth factors.

But the rule is a simplification, not an absolute law. Several factors modify molecular penetration that the simple size threshold doesn't capture:

• Skin condition: Compromised, aged, or damaged skin has different barrier properties
• Formulation: How an ingredient is delivered matters as much as what's being delivered
• Receptor location: Not all biological activity requires deep penetration
• Alternative pathways: Hair follicles and sweat glands provide routes bypassing the stratum corneum

The research on topical growth factors shows measurable clinical effects. The question isn't whether they work—multiple studies demonstrate that they do. The question is how, given the molecular size limitations.

Surface Receptor Signaling: Effects Without Deep Penetration

Here's what the research suggests: some growth factor effects don't require penetration into the dermis at all.

Epidermal growth factor (EGF) binds to EGF receptors (EGFR) present on keratinocytes—the cells comprising the outer layers of skin. When EGF binds these receptors, it triggers intracellular signaling cascades that affect cell behavior even though the EGF molecule itself stays at the surface.

Research from the Journal of Clinical Interventions in Aging explains that growth factors binding to surface receptors can trigger signaling cascades affecting deeper layers. The signal propagates through cell-to-cell communication, not through the molecule itself traveling through tissue.

Think of it like a phone call: the information reaches its destination without the phone physically moving.

Extracellular Vesicles: Nature's Delivery System

Some of the most exciting recent research focuses on extracellular vesicles (EVs) in colostrum—nanoscale packages that carry bioactive cargo, including growth factors and immunomodulatory proteins.

A 2022 study in Advanced Healthcare Materials demonstrated that colostrum-derived EVs:

• Have diameters around 100-150 nanometers
• Carry growth factors and signaling molecules as cargo
• Can be taken up by fibroblasts and endothelial cells
• Promote wound healing in animal models

These EVs may represent nature's solution to the penetration problem. Instead of requiring large proteins to squeeze through barrier layers, the proteins are packaged in membrane-bound vesicles that cells can absorb through normal uptake mechanisms.

The researchers noted that colostrum EVs were "quite resistant to freeze-drying procedures, maintaining their original characteristics and efficacy for wound repair after lyophilization." This stability suggests these delivery systems are robust enough for practical skincare applications.

The Compromised Barrier Factor

Much anti-aging skincare targets skin that isn't in pristine condition. Aged skin, sun-damaged skin, skin with inflammatory conditions—these have barrier properties different from the intact stratum corneum used in basic permeability research.

Studies on transepidermal water loss (TEWL) consistently show that barrier function declines with age. The same barrier compromise that allows moisture to escape more easily may also allow beneficial compounds to enter more readily.

This creates an interesting feedback loop: colostrum's effects on barrier repair (documented in the sheep colostrum clinical trial, which showed reduced TEWL) may actually reduce its own penetration over time as it improves barrier function. The skin that needs growth factors most may be the skin that allows them in most easily.

Follicular Delivery: The Hair Follicle Highway

Your skin isn't uniformly impermeable. Hair follicles penetrate through the stratum corneum and provide direct access to deeper tissues. Research on drug delivery increasingly recognizes transfollicular penetration as a significant route for larger molecules.

A review in Pharmaceutics noted that hair follicles can function as reservoirs and shunts for drug delivery, particularly for molecules too large for direct stratum corneum penetration. Formulations that interact with the sebum in follicles may achieve dermal delivery that wouldn't be predicted by simple molecular size rules.

Facial skin contains approximately 100-300 hair follicles per square centimeter—far more potential entry points than many people realize.

Clinical Evidence vs. Theoretical Objections

The most compelling argument for topical growth factor efficacy isn't mechanistic speculation—it's clinical results.

The randomized controlled trial on sheep colostrum cream showed measurable improvements in skin hydration, barrier function, and firmness over eight weeks. Studies on EGF serums demonstrated improvements in texture, pigmentation, and wrinkles. Wound healing research shows colostrum outperforming conventional treatments.

These aren't studies measuring growth factor levels in blood (which wouldn't be expected or even desired from topical application). They're measuring effects on skin—exactly what cosmetic formulations are designed to achieve.

If the penetration objection were absolutely correct, these clinical effects wouldn't exist. The fact that they do suggests our understanding of how topical growth factors work remains incomplete, but their efficacy is established.

What This Means for Colostrum Skincare

When we formulate our Colostrum Cream, we're working with the full matrix of bioactive compounds found in first milk—not isolated growth factors. This matters because:

1. The matrix includes natural delivery systems like extracellular vesicles
2. Multiple mechanisms are engaged, including surface receptor binding, follicular delivery, and vesicle uptake
3. Synergistic effects between components may enhance overall efficacy
4. Barrier-supporting compounds like lactoferrin and immunoglobulins work alongside growth factors

We collect colostrum from our own goats on our Washington State farm within 24 hours of birth, when bioactive compound concentrations are highest. We process it to preserve the complete matrix rather than extracting isolated components.

The science suggests that colostrum's effectiveness may depend partly on this completeness—the natural delivery systems and supporting compounds that isolated synthetic growth factors lack.

The Honest Bottom Line

Can all growth factors in colostrum penetrate to the dermis? Probably not. Does this mean topical colostrum doesn't work? The clinical evidence says otherwise.

The most likely explanation involves multiple complementary mechanisms: surface receptor signaling, extracellular vesicle delivery, follicular penetration, and effects on the epidermis that signal to deeper tissues.

Science often works this way. We observe effects we can measure. We develop hypotheses about mechanisms. We refine our understanding over time. The observation that topical colostrum improves skin condition is well-established; the complete mechanistic explanation is still being developed.

For practical skincare purposes, what matters is whether an ingredient delivers measurable benefits. For colostrum, the answer from clinical research is yes.

References

1. Bos, J. D., & Meinardi, M. M. (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology, 9(3), 165–169. https://doi.org/10.1034/j.1600-0625.2000.009003165.x
2. Quinlan, C., Engelbrecht, L., &"; Prickett, T. (2023). Topical growth factor preparations for facial skin rejuvenation: A systematic review. Journal of Cosmetic Dermatology, 22(8), 2137–2149. https://doi.org/10.1111/jocd.15644
3. Miller-Kobisher, B., Alcántara-González, J., & Pedrosa-González, F. (2021). Epidermal growth factor in aesthetics and regenerative medicine: Systematic review. Journal of Cutaneous and Aesthetic Surgery, 14(2), 137–150. https://doi.org/10.4103/JCAS.JCAS_168_20
4. Shin, J. W., Kwon, S. H., & Park, K. C. (2023). The use of epidermal growth factor in dermatological practice. International Wound Journal, 20(6), 2199–2208. https://doi.org/10.1111/iwj.14075
5. Kim, H., Kim, D. E., Han, G., Lim, N. R., Kim, E. H., Jang, Y., Cho, H., Jang, H., Kim, K. H., Kim, S. H., & Yang, Y. (2022). Harnessing the natural healing power of colostrum: Bovine milk-derived extracellular vesicles from colostrum facilitating the transition from inflammation to tissue regeneration for accelerating cutaneous wound healing. Advanced Healthcare Materials, 11(6), 2102027. https://doi.org/10.1002/adhm.202102027
6. Verma, A., Jain, A., Hurkat, P., & Jain, S. K. (2016). Transfollicular drug delivery: Current perspectives. Research and Reports in Transdermal Drug Delivery, 5, 1–17. https://doi.org/10.2147/RRTD.S75809
7. Pereira, M. N., Schulte, H. L., Duez, P., & Gehrcke, M. (2022). Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders. Asian Journal of Pharmaceutical Sciences, 17(3), 378–402. https://doi.org/10.1016/j.ajps.2022.03.002
8. Patzelt, A., & Lademann, J. (2013). Drug delivery to hair follicles. Expert Opinion on Drug Delivery, 10(6), 787–797. https://doi.org/10.1517/17425247.2013.776038
9. Jung, S., Otberg, N., Thiede, G., Richter, H., Sterry, W., Panzner, S., & Lademann, J. (2006). Innovative liposomes as a transfollicular drug delivery system: Penetration into porcine hair follicles. Journal of Investigative Dermatology, 126(8), 1728–1732. https://doi.org/10.1038/sj.jid.5700323
10. Eskens, O., & Amin, S. (2021). Challenges and effective routes for formulating and delivery of epidermal growth factors in skin care. International Journal of Cosmetic Science, 43(2), 123–130. https://doi.org/10.1111/ics.12685
11. Ganceviciene, R., Liakou, A. I., Theodoridis, A., Makrantonaki, E., & Zouboulis, C. C. (2012). Skin anti-aging strategies. Dermato-Endocrinology, 4(3), 308–319. https://doi.org/10.4161/derm.22804
12. Buranasudja, V., Muangnoi, C., Sanookpan, K., Hallis, S. P., Woodley, D. T., & Chen, M. (2022). Erythroid differentiation regulator 1 (Erdr1) promotes wound healing via activation of skin keratinocytes. Scientific Reports, 12, 7953. https://doi.org/10.1038/s41598-022-12025-1
13. Wójcik, A., Budzisz, E., & Rotsztejn, H. (2024). The efficacy of a cosmetic preparation containing sheep colostrum on mature skin: A randomized placebo-controlled double-blind study. Applied Sciences, 14(7), 2862. https://doi.org/10.3390/app14072862
14. Wójcik, A., Budzisz, E., & Rotsztejn, H. (2024). Assessment of the impact of a cosmetic product with sheep colostrum on acne skin. Applied Sciences, 14(5), 2199. https://doi.org/10.3390/app14052199
15. Bolat, E., Sarıtaş, S., Duman, H., Eker, F., Akdaşçi, E., Karav, S., & Witkowska, A. M. (2024). The potential applications of natural colostrum in skin health. Cosmetics, 11(6), 197. https://doi.org/10.3390/cosmetics11060197
16. Wójcik, A., Mitka, K., Gawlik-Dziki, U., Budzisz, E., & Rotsztejn, H. (2024). Biologically active sheep colostrum for topical treatment and skin care. International Journal of Molecular Sciences, 25(14), 7615. https://doi.org/10.3390/ijms25147615